Genetic Technologies Ltd (GENE)
NASDAQ (CM) NASDAQ (CM) Primary 
Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug
On Thursday, Amicus Therapeutics FOLD announced that it has entered into a License Agreement with Teva Pharmaceuticals Inc. TEVA.
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
BofA Securities has upgraded Fulcrum Therapeutics FULC ahead of the company's phase 3 losmapimod readout, expected by the end of October for Facioscapulohumeral muscular dystrophy (FSHD).
Eli Lilly signs research deal with AI-focused Genetic Leap
Eli Lilly has entered into a research deal with artificial intelligence-focused firm Genetic Leap for up to $409 million to develop genetic medicines, the latter said on Thursday.
Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer
SPARKS, NV / ACCESSWIRE / July 9, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG), a USA based biotechnology company is pleased to announce that the company has filed a provisional patent titled "mRNAs DIFFERENTIALLY EXPRESSED IN COLORECTAL CANCER, BREAST CANCER, AND BLADDER CANCER." The present invention generally relates to the use of mRNA genetic transcripts to (a) identify and differentiate between cancers, and (b) determine the effectiveness of a treatment for a cancer.The mRNA biomarkers uncovered by Ludwig are a sensitive dynamic genetic signal associated with cancer that opens the door for the company to participate in the emerging billion dollar diagnostic cancer screening market.
Genetic testing firm investigated over hack
A joint investigation into a data breach at DNA testing company has been launched by UK and Canadian watchdogs.
